×

nContact Supporting Continuing Medical Education Symposium on Persistent Atrial Fibrillation Treatments at Heart Rhythm Society 2015

MORRISVILLE, N.C., May 7, 2015 (GLOBE NEWSWIRE) -- nContact, a leader in the development of Arrhythmia & Cardiovascular Disease Management Programs, announced educational support for a CME Symposium at the upcoming Heart Rhythm Society (HRS) 2015 meeting in Boston, MA, next week. The program is titled “Can You Successfully Treat Persistent Atrial Fibrillation without Silencing the Posterior Left Atrium? Setting a Standard for Single-Procedure Outcomes” and is being held during lunch on Wednesday May 13, at the Westin Boston Waterfront, Grand Ballroom B.

The CME Symposium Program Director is David Callans, MD, FHRS, of the Hospital of the University of Pennsylvania, Philadelphia, PA.

Other faculty speakers will include Kenneth Civello, MD, MPH, FACS, of Our Lady of the Lake Regional Medical Center in Baton Rouge, LA; Suneet Mittal, MD, FACC, FHRS, of Valley Health System in Ridgewood, NJ; Kevin Makati, MD, FACC, FHRS, of St. Joseph’s Hospital in Tampa, FL; and Jonathan Kalman, MBBS, PhD, FHRS, of Royal Melbourne Hospital in Melbourne, Australia.

HRS attendees can register for this symposium through MediaSphere Medical at: http://www.innovationsincrm.com/paf.

nContact will be exhibiting at the HRS 36th Annual Meeting in Boston, May 13-15, Booth #1147.

About nContact, Inc.
nContact’s mission is to transform the underserved arrhythmia market through the advancement of less invasive ablation alternatives for cardiac arrhythmias. The Company is conducting the CONVERGE IDE Clinical Trial, the first head-to-head study to evaluate the Convergent Procedure to catheter ablation in persistent atrial fibrillation (AF) patients. The Company’s lead technology, EPi-Sense® Coagulation System with VisiTrax®, has CE Mark approval in Europe for the coagulation of cardiac tissue in the treatment of atrial fibrillation and atrial flutter. The EPi-Sense Coagulation System with VisiTrax is indicated for endoscopic coagulation of cardiac tissue in the U.S. nContact was founded in 2005 and is headquartered in Morrisville, North Carolina, USA. For more information, visit www.ncontactinc.com.


Media Contact: Kris McCulloch nContact, Inc. T (919) 655-1351 kmcculloch@ncontactinc.com

Source: nContact, Inc.